Title: Phase III trials of coronavirus vaccine to take place at 5 US military sites, Pentagon confirms

Spotlight: Sites are located in the Washington, D.C., San Diego and San Antonio areas

Content Text:
The Pentagon announced that five United States military sites were chosen to participate in the third phase of coronavirus vaccine trials. These trials are part of Operation Warp Speed (OWS), which aims to deliver safe and effective vaccines and therapeutics by January 2021.
“The Department of Defense continues to play a key role in the development of a potential COVID-19 vaccine,” Tom McCaffery, Assistant Secretary of Defense for Health Affairs, said in the release.
“Now that vaccines have passed the first phases of testing for safety, dosing and response, we are ready to move into the next phase where volunteers are needed to join large clinical studies. We are excited to have several sites identified to support the next steps in the vaccine development process,” McCaffery, said in the press release.
The five sites will test AZD1222, the vaccine candidate currently being developed by AstraZeneca. 
Those sites, which, according to the Pentagon’s release, are located in the Washington, D.C., San Diego and San Antonio areas, and will test AZD1222, the vaccine candidate currently being developed by AstraZeneca. The following sites were picked to participate in the phase III trials:
To evaluate the efficacy of the vaccines, health officials are asking those from hardest-hit communities to participate. The study is looking for individuals who are at high risk for contracting COVID-19 infection and, as specified on their release, these include:
These trials are part of Operation Warp Speed (OWS), the goal of which is to deliver safe and effective vaccines and therapeutics by January 2021, according to the Pentagon release.
Fox News' Lucas Tomlinson contributed to this report.